Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/22/13 12:20 | 1/17/13 | ALXA | Health | Drug | Pharmaceutical Preparations | Lansdowne Partners Austria Gmbh | C4 | T | S.m | -594 | 4.75 | 5 | -125 | -4 | 3,065 | I | -67 | -39 | 34 | -11 | -8 | -3 | -4 | 0 | -3 | -5 | -5 | -7 | -4 | 10 | |
12/27/12 16:27 | 12/26/12 | ALXA | Health | Drug | Pharmaceutical Preparations | Simms Michael J | CA | O | SVP,Oper | S | -22 | 4.90 | 7 | -5 | -52 | 4 | D | -61 | -44 | 5 | 6 | 19 | -1 | -17 | -22 | 0 | 2 | -8 | -9 | -11 | -3 |
12/27/12 16:19 | 12/26/12 | ALXA | Health | Drug | Pharmaceutical Preparations | Cassella James V | CA | O | EVP,R,D, | S | -22 | 4.90 | 7 | -5 | -83 | 1 | D | -61 | -44 | 5 | 6 | 19 | -1 | -17 | -22 | 0 | 2 | -8 | -9 | -11 | -3 |
8/29/12 17:39 | 8/27/12 | ALXA | Health | Drug | Pharmaceutical Preparations | Cassella James V | CA | O | EVP,R,D, | S | -41 | 4.14 | 2 | -10 | -64 | 6 | D | -84 | -63 | -26 | 26 | 32 | 53 | 17 | 13 | -1 | 2 | -4 | 15 | -3 | -3 |
8/29/12 17:35 | 8/27/12 | ALXA | Health | Drug | Pharmaceutical Preparations | King Thomas Braxton | CA | DO | P,CEO | S | -41 | 4.14 | 2 | -10 | -25 | 30 | M | -84 | -63 | -26 | 26 | 32 | 53 | 17 | 13 | -1 | 2 | -4 | 15 | -3 | -3 |
8/29/12 17:30 | 8/27/12 | ALXA | Health | Drug | Pharmaceutical Preparations | Moreland Darl | CA | O | SVP,Qual | S | -41 | 4.14 | 2 | -10 | -84 | 2 | D | -84 | -63 | -26 | 26 | 32 | 53 | 17 | 13 | -1 | 2 | -4 | 15 | -3 | -3 |
8/29/12 17:27 | 8/27/12 | ALXA | Health | Drug | Pharmaceutical Preparations | Simms Michael J | CA | O | SVP,Oper | S | -41 | 4.14 | 2 | -10 | -56 | 8 | D | -84 | -63 | -26 | 26 | 32 | 53 | 17 | 13 | -1 | 2 | -4 | 15 | -3 | -3 |
8/29/12 17:25 | 8/27/12 | ALXA | Health | Drug | Pharmaceutical Preparations | Oki Mark K | CA | O | SVP,CFO, | S | -41 | 4.14 | 2 | -10 | -73 | 4 | D | -84 | -63 | -26 | 26 | 32 | 53 | 17 | 13 | -1 | 2 | -4 | 15 | -3 | -3 |
6/8/12 16:57 | 6/6/12 | ALXA | Health | Drug | Pharmaceutical Preparations | King Thomas Braxton | CA | DO | P,CEO | S | -22 | 0.3381 | 0 | -66 | -14 | 396 | D | -89 | -79 | -67 | -48 | -44 | -17 | -11 | 0 | -3 | -26 | 13 | 32 | 46 | 30 |
6/8/12 16:56 | 6/6/12 | ALXA | Health | Drug | Pharmaceutical Preparations | Cassella James V | CA | O | SVP,Rese | S | -16 | 0.3381 | 0 | -46 | -23 | 158 | D | -89 | -79 | -67 | -48 | -44 | -17 | -11 | 0 | -3 | -26 | 13 | 32 | 46 | 30 |
6/8/12 16:51 | 6/6/12 | ALXA | Health | Drug | Pharmaceutical Preparations | Oki Mark K | CA | O | VP Fin C | S | -11 | 0.3381 | 0 | -32 | -19 | 138 | D | -89 | -79 | -67 | -48 | -44 | -17 | -11 | 0 | -3 | -26 | 13 | 32 | 46 | 30 |
6/8/12 16:46 | 6/6/12 | ALXA | Health | Drug | Pharmaceutical Preparations | Simms Michael J | CA | O | SVP,Oper | S | -16 | 0.3381 | 0 | -46 | -20 | 180 | D | -89 | -79 | -67 | -48 | -44 | -17 | -11 | 0 | -3 | -26 | 13 | 32 | 46 | 30 |
1/20/12 13:43 | 12/30/11 | ALXA | Health | Drug | Pharmaceutical Preparations | Occitan Capital Management Inc. | E9 | TH | See rema | S.d | -16 | 0.8477 | 0 | -19 | -1 | 3,644 | I | -69 | -40 | -56 | -39 | -22 | -2 | -15 | 0 | 0 | -9 | -39 | -26 | -55 | -43 |
5/7/10 16:30 | 5/5/10 | ALXA | Health | Drug | Pharmaceutical Preparations | Moretti August J | CA | O | SVP,CFO, | S.d | -35 | 3.50 | 0 | -10 | -19 | 43 | D | -50 | 101 | 53 | 21 | 19 | 5 | 1 | -4 | 1 | 10 | -13 | -29 | -73 | -62 |
12/21/09 16:45 | 12/16/09 | ALXA | Health | Drug | Pharmaceutical Preparations | Cassella James V | CA | O | SVP,Rese | S.am | -54 | 2.23 | 0 | -24 | -67 | 12 | D | -73 | -39 | -21 | -13 | -2 | -7 | -6 | -20 | 3 | 7 | 16 | 31 | 31 | -48 |
12/21/09 16:41 | 12/16/09 | ALXA | Health | Drug | Pharmaceutical Preparations | King Thomas Braxton | CA | DO | P,CEO | S.am | -100 | 2.23 | 0 | -45 | -19 | 192 | D | -73 | -39 | -21 | -13 | -2 | -7 | -6 | -20 | 3 | 7 | 16 | 31 | 31 | -48 |
12/21/09 16:39 | 12/16/09 | ALXA | Health | Drug | Pharmaceutical Preparations | Simms Michael J | CA | O | SVP,Oper | S.am | -22 | 2.23 | 0 | -10 | -27 | 26 | D | -73 | -39 | -21 | -13 | -2 | -7 | -6 | -20 | 3 | 7 | 16 | 31 | 31 | -48 |
12/21/09 16:38 | 12/16/09 | ALXA | Health | Drug | Pharmaceutical Preparations | Moretti August J | CA | O | SVP,CFO, | S.am | -31 | 2.23 | 0 | -14 | -30 | 33 | D | -73 | -39 | -21 | -13 | -2 | -7 | -6 | -20 | 3 | 7 | 16 | 31 | 31 | -48 |
12/18/09 18:46 | 12/16/09 | ALXA | Health | Drug | Pharmaceutical Preparations | Cassella James V | CA | O | SVP,Rese | S.m | -54 | 2.23 | 0 | -24 | -67 | 12 | D | -72 | -31 | -14 | -13 | 4 | -3 | -2 | -6 | 9 | 7 | 25 | 39 | 41 | -35 |
12/18/09 18:45 | 12/16/09 | ALXA | Health | Drug | Pharmaceutical Preparations | King Thomas Braxton | CA | DO | P,CEO | S.m | -100 | 2.23 | 0 | -45 | -19 | 192 | D | -72 | -31 | -14 | -13 | 4 | -3 | -2 | -6 | 9 | 7 | 25 | 39 | 41 | -35 |
12/18/09 18:44 | 12/16/09 | ALXA | Health | Drug | Pharmaceutical Preparations | Simms Michael J | CA | O | SVP,Oper | S.m | -22 | 2.23 | 0 | -10 | -27 | 26 | D | -72 | -31 | -14 | -13 | 4 | -3 | -2 | -6 | 9 | 7 | 25 | 39 | 41 | -35 |
12/18/09 18:44 | 12/16/09 | ALXA | Health | Drug | Pharmaceutical Preparations | Moretti August J | CA | O | SVP,CFO, | S.m | -31 | 2.23 | 0 | -14 | -30 | 33 | D | -72 | -31 | -14 | -13 | 4 | -3 | -2 | -6 | 9 | 7 | 25 | 39 | 41 | -35 |
8/11/08 19:02 | 8/11/08 | ALXA | Health | Drug | Pharmaceutical Preparations | King Thomas Braxton | CA | DO | P,CEO | S | -71 | 5.67 | 0 | -13 | -9 | 123 | I | -18 | -39 | -18 | -11 | 36 | 13 | -6 | -8 | 0 | 1 | -9 | -70 | -59 | -61 |
5/13/08 16:25 | 5/12/08 | ALXA | Health | Drug | Pharmaceutical Preparations | King Thomas Braxton | CA | DO | P,CEO | S | -76 | 6.12 | 0 | -13 | -8 | 136 | I | -31 | -39 | -18 | -11 | -18 | -9 | -10 | -4 | -7 | 0 | -31 | -1 | -58 | -70 |
4/2/08 16:36 | 4/1/08 | ALXA | Health | Drug | Pharmaceutical Preparations | Moretti August J | CA | O | SVP,CFO, | S.d | -36 | 7.17 | 0 | -5 | -36 | 9 | D | -25 | -42 | -14 | -10 | 14 | 8 | 8 | 5 | -3 | -2 | -9 | -45 | -32 | -68 |
2/12/08 16:35 | 2/11/08 | ALXA | Health | Drug | Pharmaceutical Preparations | King Thomas Braxton | CA | DO | P,CEO | S | -83 | 6.66 | 0 | -13 | -8 | 145 | I | -37 | -31 | -9 | -18 | -1 | 8 | 2 | 0 | -1 | 6 | -8 | -11 | -60 | |
1/3/08 16:08 | 1/2/08 | ALXA | Health | Drug | Pharmaceutical Preparations | Moretti August J | CA | O | SVP,CFO, | S.d | -39 | 7.89 | 0 | -5 | -36 | 9 | D | -31 | -14 | -13 | 8 | 2 | 1 | -3 | -5 | -4 | -17 | -11 | -50 | -60 | |
11/13/07 10:21 | 11/9/07 | ALXA | Health | Drug | Pharmaceutical Preparations | King Thomas Braxton | CA | DO | P,CEO | S | -90 | 7.20 | 0 | -13 | -7 | 160 | I | -6 | -27 | -12 | -20 | -9 | -7 | 0 | 1 | 0 | 3 | -10 | -24 | -67 | |
10/3/07 13:23 | 10/1/07 | ALXA | Health | Drug | Pharmaceutical Preparations | Moretti August J | CA | O | SVP,CFO, | S.d | -43 | 8.59 | 0 | -5 | -41 | 7 | D | 13 | -25 | -1 | 17 | 15 | 4 | 0 | 0 | 4 | -11 | -13 | -22 | -49 | |
8/13/07 16:30 | 8/9/07 | ALXA | Health | Drug | Pharmaceutical Preparations | King Thomas Braxton | CA | DO | P,CEO | S.m | -114 | 9.15 | 0 | -13 | -7 | 173 | I | 59 | -9 | 0 | 20 | 9 | 18 | 22 | -12 | -14 | -11 | -20 | -26 | -36 | |
8/1/07 15:28 | 8/1/07 | ALXA | Health | Drug | Pharmaceutical Preparations | Moretti August J | CA | O | SVP,CFO, | S.d | -43 | 8.66 | 0 | -5 | -41 | 7 | D | 20 | -7 | -12 | -8 | -5 | 4 | 0 | -4 | -8 | -13 | -8 | -27 | -33 | |
4/3/07 15:05 | 4/2/07 | ALXA | Health | Drug | Pharmaceutical Preparations | Moretti August J | CA | O | SVP,CFO, | S.d | -124 | 12.37 | 1 | -10 | -64 | 6 | D | 21 | 42 | 1 | 6 | 30 | 20 | -13 | 4 | 3 | -12 | -25 | -23 | -38 | |
12/8/06 16:15 | 12/7/06 | ALXA | Health | Drug | Pharmaceutical Preparations | Moretti August J | CA | O | SVP,CFO, | S | -17 | 8.30 | 0 | -2 | -26 | 6 | D | -5 | 13 | -1 | 4 | 2 | -3 | -5 | 28 | 31 | 7 | 10 | 0 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |